首页> Clinical Pharmacology and Therapeutics> ANALYSIS OF LABELING RECOMMENDATIONS IN SELECTED SPECIFIC POPULATIONS IN US FOOD AND DRUG ADMINISTRATION (FDA)-APPROVED NEW MOLECULAR ENTITIES BETWEEN 1998 AND 2017.

ANALYSIS OF LABELING RECOMMENDATIONS IN SELECTED SPECIFIC POPULATIONS IN US FOOD AND DRUG ADMINISTRATION (FDA)-APPROVED NEW MOLECULAR ENTITIES BETWEEN 1998 AND 2017.

导出原文传递

翻译打印收藏纠错

作者： Shugg, T. ^[1] ; Faruque, F. ^[2] ; Younis, I. ^[3]

作者单位： Indiana Univ, Indianapolis, IN 46204 USA ^[1] Univ Maryland, Baltimore, MD 21201 USA ^[2] Astellas Pharma, Northbrook, IL USA ^[3]

发布时间 2020-10-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Pharmacology and Therapeutics

2020年107卷S1期

S106-S106页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical Pharmacology and Therapeutics

2020年107卷S1期

S106-S106页

检索历史清除

ANALYSIS OF LABELING RECOMMENDATIONS IN SELECTED SPECIFIC POPULATIONS IN US FOOD AND DRUG ADMINISTRATION (FDA)-APPROVED NEW MOLECULAR ENTITIES BETWEEN 1998 AND 2017.

Clinical Pharmacology and Therapeutics

相似文献

Clinical Pharmacology and Therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

ANALYSIS OF LABELING RECOMMENDATIONS IN SELECTED SPECIFIC POPULATIONS IN US FOOD AND DRUG ADMINISTRATION (FDA)-APPROVED NEW MOLECULAR ENTITIES BETWEEN 1998 AND 2017.

Clinical Pharmacology and Therapeutics

相似文献

Clinical Pharmacology and Therapeutics

相关期刊

检索历史清除